The project involves the rehabilitation and extension of Lapland Central Hospital in Rovaniemi, Finland.
Benefits are expected to arise from the project's contribution to the overall health strategy of the region through appropriately configured infrastructure and organisation of care. The investment will allow for the reorganisation of service delivery and the introduction of up-to-date technologies to improve efficiency and effectiveness in order to respond to the evolving demographic and epidemiological needs of an ageing population. The soundness and quality of the underlying project, including its financial affordability and wider impacts on the community, will be examined and confirmed during appraisal.
As a hospital investment, this project addresses the sub-optimal investment situation in the European health infrastructure due to market failures originating from the public goods nature of hospitals and the large health externalities they generate. The project generates positive externalities through the provision of improved health services, enhanced emergency preparedness and the reduction of energy consumption. By providing integrated and efficient medical services of higher quality, the project aims to respond to the changing needs of an ageing population and to the developments in healthcare practices. The operation will ensure that Lapland Hospital District has sufficient financial resources for the timely implementation of the project; it will allow it to spread out the investment and ensure that the tenor of the loan links in with the economic life of the asset being financed. It will also complement funding from other multilateral financiang institutions.
Hospitals are not specifically mentioned in the EIA Directive 2014/52/EU amending the Directive 2011/92/EU, though the project might be covered by Annex II of the Directive in relation to urban development. The compliance with requirements of the EIA Directive 2011/92/EU as amended by 2014/52/EU on Environmental Impact Assessment (EIA) and Habitats Directive will be verified during appraisal. It is expected that the project will bear wider benefits to the community as healthcare is an element of social cohesion and economic development.
The Bank will require the Promoter to ensure that contracts for the implementation of the project shall be tendered in accordance with the relevant applicable EU procurement legislation (Directives 2014/24/EU and/or 2014/25/EU and/or 2014/23/EU as well as Directives 89/665/EEC and 92/13/EEC) as interpreted by the Court of Justice of the EU, with publication of tender notices in the Official Journal of the EU, as and where required.
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).
News & Stories
General enquiries and comments
The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.
Zero tolerance against fraud and corruption
The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.